Reducing severe cutaneous adverse and type B adverse drug reactions using pre-stored human leukocyte antigen genotypes.
Kye-Hwa LeeDong Yoon KangHyun Hwa KimYi-Jun KimHyo Jung KimJu Han KimEun Young SongJames YunHye-Ryun KangPublished in: Clinical and translational allergy (2022)
Utilization of pre-stored HLA data can prevent type B ADRs including SCARs by screening high-risk patients.